BCRX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.80%

Insider Buying (Last 12 Months): $596,337.56

Insider Selling (Last 12 Months): $82,486.00

BioCryst Pharmaceuticals Insider Trading History Chart

BioCryst Pharmaceuticals Share Price & Price History

^$6.52

▲ +0.11 (1.72%)

As of 07/5/2024 01:00 AM ET

Days: 30 | 90 | 365

The asset beating inflation by 4x

From Colonial Metals | Ad

Central Bank Gold Heist In Progress Central banks are buying gold at record rates... and billionaire investors are buying right along with them. Even Warren Buffett put over $500 million into gold. And with the help of a tax and penalty-free "Trump Loophole, " these investors are investing retirement into gold and other precious metals without having to put up any of their own cash. In our Free Retirement Protection Kit, we reveal all the details on how the rich use this loophole to protect and growth their retirement wealth in any economy…and show you how you can use it too.

Click here to get your free copy today.

BioCryst Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/24/2024	Amy E Mckee	Director	Sell	8,600	$6.32	$54,352.00	27,831
6/17/2024	Machelle Sanders	Director	Sell	4,689	$6.00	$28,134.00	27,742
5/30/2024	Alan G Levin	Director	Buy	7,861	$6.36	$49,995.96	44,951
5/24/2024	Steve Aselage	Director	Buy	2,500	$6.40	$16,000.00	2,500
5/20/2024	Nancy J. Hutson	Director	Buy	5,000	$6.38	$31,900.00	86,818
5/14/2024	Anthony Doyle	CFO	Buy	36,300	$5.57	$202,191.00	266,744
5/14/2024	Helen M Thackray	Insider	Buy	30,000	$5.86	$175,800.00	272,139
5/13/2024	Steven K Galson	Director	Buy	21,940	$5.49	$120,450.60	51,551
6/15/2023	Machelle Sanders	Director	Sell	4,000	$7.98	$31,920.00	25,611
2/1/2023	Jon P. Stonehouse	CEO	Sell	100,000	$10.38	$1,038,000.00	1,008,739
12/15/2022	Anthony Doyle	CFO	Sell	5,700	$10.90	$62,130.00	163,966
12/15/2022	Helen M Thackray	Insider	Sell	3,125	$10.89	$34,031.25	133,275
12/15/2022	Jon P. Stonehouse	CEO	Sell	14,100	$10.90	$153,690.00	887,730
12/15/2022	Michael L Jones	Director	Sell	445	$10.90	$4,850.50	10,753
12/2/2022	Jon P. Stonehouse	CEO	Sell	82,656	$12.80	$1,057,996.80	901,830
12/1/2022	Michael L Jones	Director	Sell	8,600	$13.01	$111,886.00	11,198
11/14/2022	Yarlagadda S. Babu	Insider	Sell	31,515	$13.88	$437,428.20	298,541
4/1/2022	Helen M Thackray	Insider	Sell	7,600	$16.20	$123,120.00	136,400
2/15/2022	George B. Abercrombie	Director	Sell	5,000	$18.50	$92,500.00
1/11/2022	Jon P. Stonehouse	CEO	Sell	184,000	$15.04	$2,767,360.00
12/7/2021	Yarlagadda S. Babu	Insider	Sell	30,100	$12.20	$367,220.00
11/24/2021	Vincent Milano	Director	Buy	7,500	$12.19	$91,425.00
11/23/2021	Anthony Doyle	CFO	Buy	35,258	$12.48	$440,019.84
11/15/2021	George B. Abercrombie	Director	Sell	5,000	$12.27	$61,350.00
10/15/2021	Nancy J. Hutson	Director	Sell	105,000	$15.40	$1,617,000.00
9/10/2021	George B. Abercrombie	Director	Sell	74,000	$15.09	$1,116,660.00
7/15/2021	George B. Abercrombie	Director	Sell	5,000	$15.69	$78,450.00	8,000

The asset beating inflation by 4x

From Colonial Metals | Ad

Click here to get your free copy today.

SEC Filings (Institutional Ownership Changes) for BioCryst Pharmaceuticals (NASDAQ:BCRX)

85.88% of BioCryst Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

BioCryst Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/17/2024	Tidal Investments LLC	55,560	$0.28M	0.0%	N/A	0.027%
5/16/2024	Redwood Investment Management LLC	122,270	$0.62M	0.1%	N/A	0.059%
5/16/2024	California State Teachers Retirement System	184,788	$0.94M	0.0%	-7.6%	0.090%
5/16/2024	Jacobs Levy Equity Management Inc.	156,119	$0.79M	0.0%	+62.0%	0.076%
5/16/2024	Kynam Capital Management LP	6,527,491	$33.16M	3.5%	+41.9%	3.163%
5/15/2024	Sarissa Capital Management LP	1,094,168	$5.56M	1.0%	+9.4%	0.530%
5/15/2024	Price T Rowe Associates Inc. MD	130,775	$0.67M	0.0%	+15.0%	0.063%
5/14/2024	Nan Fung Group Holdings Ltd	36,847	$0.19M	0.2%	+106.5%	0.018%
5/14/2024	EntryPoint Capital LLC	42,679	$0.22M	0.2%	+689.8%	0.021%
5/14/2024	Shell Asset Management Co.	21,854	$0.11M	0.0%	N/A	0.011%
5/14/2024	Natixis	11,684	$59K	0.0%	+400.6%	0.006%
5/13/2024	Seven Eight Capital LP	11,254	$57K	0.0%	N/A	0.005%
5/10/2024	Vanguard Group Inc.	17,676,767	$89.80M	0.0%	-0.5%	8.567%
5/8/2024	ProShare Advisors LLC	48,503	$0.25M	0.0%	+9.1%	0.024%
5/8/2024	Russell Investments Group Ltd.	58,725	$0.30M	0.0%	+200.8%	0.028%
5/8/2024	Inspire Investing LLC	69,466	$0.35M	0.0%	+9.7%	0.034%
5/7/2024	Susquehanna Fundamental Investments LLC	64,365	$0.33M	0.0%	N/A	0.031%
5/7/2024	Swiss National Bank	363,968	$1.85M	0.0%	-2.5%	0.176%
5/7/2024	SG Americas Securities LLC	13,548	$69K	0.0%	-79.5%	0.007%
5/2/2024	Mutual of America Capital Management LLC	212,781	$1.08M	0.0%	-4.0%	0.103%
5/1/2024	BNP Paribas Financial Markets	167,782	$0.85M	0.0%	-78.8%	0.081%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	138,074	$0.70M	0.0%	+13.0%	0.067%
4/30/2024	J.W. Cole Advisors Inc.	12,600	$64K	0.0%	-37.3%	0.006%
4/29/2024	China Universal Asset Management Co. Ltd.	39,639	$0.20M	0.0%	+67.3%	0.019%
4/24/2024	Assenagon Asset Management S.A.	386,885	$1.97M	0.0%	-26.9%	0.188%
4/23/2024	Rice Hall James & Associates LLC	2,151,545	$10.93M	0.6%	-2.1%	1.044%
4/5/2024	Los Angeles Capital Management LLC	89,614	$0.46M	0.0%	+68.0%	0.043%
3/11/2024	Vanguard Group Inc.	17,763,720	$106.41M	0.0%	+15.4%	8.617%
3/5/2024	Fisher Asset Management LLC	2,884,569	$17.28M	0.0%	-9.4%	1.399%
2/27/2024	Counterweight Ventures LLC	13,500	$81K	0.1%	N/A	0.007%
2/20/2024	Quarry LP	9,000	$54K	0.0%	N/A	0.004%
2/14/2024	Oracle Investment Management Inc.	535,558	$3.21M	2.0%	-3.6%	0.261%
2/14/2024	Braidwell LP	5,718,477	$34.25M	1.3%	+6.6%	2.792%
2/14/2024	Avoro Capital Advisors LLC	13,050,000	$78.17M	1.1%	+13.0%	6.372%
2/14/2024	Kynam Capital Management LP	4,600,000	$27.55M	3.1%	+46.8%	2.246%
2/13/2024	Tower Research Capital LLC TRC	10,420	$62K	0.0%	+131.1%	0.005%
2/13/2024	Rafferty Asset Management LLC	955,587	$5.72M	0.0%	+18.3%	0.467%
2/12/2024	Capstone Investment Advisors LLC	18,650	$0.11M	0.0%	N/A	0.009%
2/9/2024	Aigen Investment Management LP	12,670	$76K	0.0%	-91.7%	0.006%
2/9/2024	GW&K Investment Management LLC	2,337,683	$14M	0.1%	-9.1%	1.141%
2/9/2024	Trexquant Investment LP	421,516	$2.53M	0.1%	-28.9%	0.206%
2/9/2024	Norges Bank	2,216,612	$13.28M	0.0%	N/A	1.082%
2/8/2024	Panagora Asset Management Inc.	669,067	$4.01M	0.0%	-8.0%	0.327%
2/8/2024	Pinnacle Wealth Planning Services Inc.	20,561	$0.12M	0.0%	N/A	0.010%
2/7/2024	Jump Financial LLC	128,771	$0.77M	0.0%	-68.2%	0.063%
2/7/2024	BNP Paribas Financial Markets	790,163	$4.73M	0.0%	+45.5%	0.386%
2/7/2024	Teacher Retirement System of Texas	43,827	$0.26M	0.0%	-18.3%	0.021%
2/7/2024	E Fund Management Co. Ltd.	51,317	$0.31M	0.0%	+23.7%	0.025%
2/6/2024	Charles Schwab Investment Management Inc.	1,594,436	$9.55M	0.0%	+9.1%	0.778%
2/6/2024	Amalgamated Bank	24,257	$0.15M	0.0%	-7.2%	0.012%
2/6/2024	Los Angeles Capital Management LLC	53,330	$0.32M	0.0%	+61.0%	0.026%
2/6/2024	Swiss National Bank	373,468	$2.24M	0.0%	-10.1%	0.182%
2/6/2024	Fisher Asset Management LLC	2,884,097	$17.28M	0.0%	-9.5%	1.408%
2/5/2024	Victory Capital Management Inc.	26,842	$0.16M	0.0%	+31.5%	0.013%
2/1/2024	New York State Common Retirement Fund	59,075	$0.35M	0.0%	-23.2%	0.029%
2/1/2024	Handelsbanken Fonder AB	45,900	$0.28M	0.0%	+29.3%	0.022%
1/31/2024	abrdn plc	504,528	$3.02M	0.0%	N/A	0.246%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	47,359	$0.28M	0.0%	+27.1%	0.023%
1/30/2024	Mackenzie Financial Corp	23,439	$0.14M	0.0%	+74.7%	0.011%
1/26/2024	Mutual of America Capital Management LLC	221,552	$1.33M	0.0%	-1.7%	0.108%
1/25/2024	MA Private Wealth	12,700	$76K	0.0%	N/A	0.006%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	122,180	$0.73M	0.0%	+6.3%	0.060%
1/24/2024	China Universal Asset Management Co. Ltd.	23,692	$0.14M	0.0%	+387.0%	0.012%
1/19/2024	JGP Global Gestao de Recursos Ltda.	10,650	$64K	0.1%	N/A	0.005%
1/17/2024	Assenagon Asset Management S.A.	529,419	$3.17M	0.0%	-52.3%	0.258%
1/12/2024	SG Americas Securities LLC	66,223	$0.40M	0.0%	N/A	0.032%
12/18/2023	Vanguard Group Inc.	15,392,319	$108.98M	0.0%	+2.0%	7.515%
11/17/2023	Jacobs Levy Equity Management Inc.	470,137	$3.33M	0.0%	-59.3%	0.230%
11/15/2023	GSA Capital Partners LLP	191,527	$1.36M	0.1%	+167.8%	0.094%
11/15/2023	Rock Springs Capital Management LP	2,551,226	$18.06M	0.5%	+2.2%	1.246%
11/15/2023	Kynam Capital Management LP	3,133,193	$22.18M	3.6%	+10.0%	1.530%
11/15/2023	ELCO Management Co. LLC	31,811	$0.23M	0.2%	+134.9%	0.016%
11/15/2023	AXQ Capital LP	23,134	$0.16M	0.1%	+31.9%	0.011%
11/14/2023	Braidwell LP	5,362,980	$37.97M	1.2%	+92.1%	2.619%
11/14/2023	Gotham Asset Management LLC	69,033	$0.49M	0.0%	N/A	0.034%
11/14/2023	Deerfield Management Company L.P. Series C	3,286,000	$23.27M	0.5%	+148.6%	1.604%
11/14/2023	Teza Capital Management LLC	36,904	$0.26M	0.0%	+12.8%	0.018%
11/14/2023	Trexquant Investment LP	592,612	$4.20M	0.1%	+76.6%	0.289%
11/14/2023	Profund Advisors LLC	136,652	$0.97M	0.1%	-22.7%	0.067%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	542,776	$3.84M	0.0%	+35.3%	0.265%
11/13/2023	Algert Global LLC	207,095	$1.47M	0.1%	-29.0%	0.101%
11/13/2023	Healthcare of Ontario Pension Plan Trust Fund	384,000	$2.72M	0.0%	N/A	0.187%
11/13/2023	Visionary Wealth Advisors	33,540	$0.24M	0.0%	-13.0%	0.016%
11/13/2023	Silverarc Capital Management LLC	791,671	$5.61M	1.7%	+4.0%	0.387%
11/13/2023	Aigen Investment Management LP	153,474	$1.09M	0.2%	+96.0%	0.075%
11/13/2023	FMR LLC	2,953,373	$20.91M	0.0%	+0.1%	1.442%
11/13/2023	Rafferty Asset Management LLC	807,888	$5.72M	0.0%	-17.1%	0.394%
11/13/2023	Kestra Advisory Services LLC	18,779	$0.13M	0.0%	-28.0%	0.009%
11/13/2023	PNC Financial Services Group Inc.	11,917	$84K	0.0%	-33.6%	0.006%
11/13/2023	E Fund Management Co. Ltd.	41,497	$0.29M	0.0%	-20.8%	0.020%
11/9/2023	Rhumbline Advisers	295,335	$2.09M	0.0%	-5.9%	0.156%
11/9/2023	Deutsche Bank AG	99,711	$0.71M	0.0%	+11.8%	0.053%
11/9/2023	Mutual of America Capital Management LLC	225,323	$1.60M	0.0%	+2.5%	0.119%
11/9/2023	UBS Group AG	305,951	$2.17M	0.0%	-21.2%	0.161%
11/8/2023	Charles Schwab Investment Management Inc.	1,460,807	$10.34M	0.0%	+1.3%	0.771%
11/8/2023	Swiss National Bank	415,368	$2.94M	0.0%	+1.2%	0.219%
11/7/2023	Virtus ETF Advisers LLC	38,321	$0.27M	0.2%	-11.5%	0.020%
11/7/2023	Quantbot Technologies LP	64,100	$0.45M	0.0%	N/A	0.034%
11/7/2023	New York State Common Retirement Fund	76,896	$0.54M	0.0%	+23.2%	0.041%
11/7/2023	Barclays PLC	547,328	$3.88M	0.0%	-0.4%	0.289%

Data available starting January 2016

BioCryst Pharmaceuticals, Inc., a biotechnology company, develops oral small-molecule and protein therapeutics to treat rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX10013, an oral factor D inhibitor for complement-mediated diseases. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.

Today's Range

Now: $6.52

$6.36

$6.55

50 Day Range

MA: $6.01

$4.13

$6.79

52 Week Range

Now: $6.52

$4.03

$7.95

Volume

1,404,452 shs

Average Volume

3,276,922 shs

Market Capitalization

$1.35 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.88

Who are the company insiders with the largest holdings of BioCryst Pharmaceuticals?: BioCryst Pharmaceuticals' top insider shareholders include:
Jon P Stonehouse (CEO)
Yarlagadda S Babu (Insider)
Helen M Thackray (Insider)
Anthony Doyle (CFO)
Nancy J Hutson (Director)
Steven K Galson (Director)
Alan G Levin (Director)
Amy E Mckee (Director)
Machelle Sanders (Director)
Michael L Jones (Director)
Steve Aselage (Director)
Learn More about top insider investors at BioCryst Pharmaceuticals.